Access Official Technical PDF

Share Summary:LinkedInEmail

Scaling semiconductor manufacturing requires more than a promising material process: deposition equipment must also deliver uniform results across commercially relevant wafer sizes. BluGlass’s RPCVD technology project, announced with a $250,000 co-funded grant from the Advanced Manufacturing Growth Centre (AMGC), aimed to address that challenge and support onshore production of laser diodes, LEDs and other semiconductor devices.

The project focused on developing and commercialising Remote Plasma Chemical Vapour Deposition (RPCVD) equipment. Its broader industrial significance lies in the effort to combine plasma-source design, deposition uniformity and equipment scalability in a platform intended for advanced manufacturing.

Why deposition scale and uniformity matter

Semiconductor devices are built through processes that deposit material onto a substrate. For these processes to support commercial production, manufacturers need equipment designed to handle larger wafers while maintaining precise, consistent deposition. The BluGlass project targeted large-size commercial wafers for the manufacture of laser diodes and light-emitting diodes, as well as semiconductor manufacturing platforms and chips.

BluGlass proposed a high-density, large-scale plasma source designed to provide ultra-precision uniformity during semiconductor device deposition. The distributed source concept was intended to scale to large industrial machines, including equipment configured for multiple 8-inch wafers. These were project design goals, rather than reported production results.

The source also described a specific upgrade for the company’s BLG-300 system. The planned plasma source was intended to support uniform deposition on either a single 12-inch wafer or multiple 4-inch wafers. Such flexibility is relevant to manufacturers evaluating equipment configurations for different development and production needs, although the announcement did not report completed validation or commercial performance.

RPCVD technology and hybrid deposition

A central objective was to develop the RPCVD process as a commercial manufacturing platform. BluGlass said the new design was intended to be scalable across MOCVD platforms used in the industry and to support hybrid growth, combining MOCVD and RPCVD in a single deposition chamber. The stated aim was to make the advantages of both growth techniques available within one platform.

For equipment designers and process engineers, this proposed hybrid approach matters because it frames the project around integration as well as scale. Rather than treating RPCVD as a standalone development, the plan sought compatibility with existing platform approaches and the ability to use both deposition techniques within a chamber. The announcement did not specify process recipes, throughput figures or comparative performance results, so those outcomes should be understood as development objectives, not established capabilities.

BluGlass’s technology was described as a process for growing advanced materials including gallium nitride (GaN) and indium gallium nitride (InGaN). The company identified these materials as relevant to high-efficiency devices used in areas such as lighting, displays, virtual reality systems, and industrial cutting and welding. Its stated rationale for RPCVD included a low-temperature, low-hydrogen growth platform, with potential benefits such as greater substrate flexibility and the possibility of new applications.

Australian partners contribute specialist capabilities

The project brought together organisations with complementary roles across design, simulation, device testing and component prototyping. The Space Plasma, Power and Propulsion Laboratory at the Australian National University was to contribute to plasma-source design, simulation and testing. AKELA Laser was to support laser-diode packaging and testing, while Objective 3D was assigned metal 3D design, testing and rapid prototyping for critical plasma-source components.

This collaboration linked deposition-system development with downstream device work and the fabrication of equipment components. For industrial automation and manufacturing teams, that structure illustrates why complex equipment programmes often depend on coordination across process engineering, component design and application testing—not solely on the deposition tool itself.

From development project to onshore manufacturing

AMGC’s matched funding was intended to assist BluGlass in developing and commercialising its RPCVD technology. The anticipated outcome was an advanced, high-throughput laser-diode foundry business in Australia, alongside local manufacture of higher-quality, more efficient laser and LED products and semiconductor platforms.

The announcement also set out projected economic outcomes, including nine additional engineering and scientific roles during the project and the potential for up to 50 new jobs following successful completion. It presented revenue targets for FY 2025 that depended on technical milestones, customer demand and market growth. These were forward-looking expectations in the 2020 announcement, not confirmation that the targets or employment outcomes were later achieved.

For plant managers, operations leaders and system integrators, the practical lesson is that bringing semiconductor production onshore involves linked technical and operational questions: Can the deposition source scale to the required wafer configuration? Can uniformity be maintained? How will the process integrate with other growth methods and device-testing activities? The project’s scope addressed these questions through equipment development and collaboration, while leaving performance validation as a necessary step in commercialisation.

What the project signals for semiconductor equipment development

BluGlass’s AMGC-backed initiative illustrates an Australian effort to develop domestic capability in a specialised part of semiconductor manufacturing. Its focus on wafer-scale plasma-source design, potential MOCVD-RPCVD integration and local partner expertise reflects the complexity of moving a deposition technology toward an industrial platform.

The wider implication is not that the project had already proven commercial-scale performance, but that equipment scalability and process integration were explicit development priorities. For manufacturers assessing emerging deposition technologies, the useful measures remain demonstrated uniformity, compatibility with intended wafer formats, process validation and readiness for production. The project’s stated goals provide a framework for understanding what it set out to develop, while its projected commercial and economic benefits remain contingent on successful technical milestones and market conditions.

Access Official Technical PDF

About The Author